APIMEDS PHARMACEUTICALS US, INC. (APUS) Operating cash flow 2023–2025
APIMEDS PHARMACEUTICALS US, INC. (APUS) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$8.9MFY2025 · since FY2023: -$627,790 → -$8.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$8.9M | -1116.8% |
| FY2024 | -$733,526 | -16.8% |
| FY2023 | -$627,790 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More APUS financial trends
APUS RevenueAPUS Net incomeAPUS Net marginAPUS Gross profitAPUS Gross marginAPUS Operating incomeAPUS Operating marginAPUS Free cash flowAPUS Capital expendituresAPUS Return on equityAPUS Stock buybacksAPUS Dividends paidAPUS Total assetsAPUS Total liabilitiesAPUS Shareholders’ equityAPUS overview →